Australia launches clinical trials website to sharpen patient access for PhIII
22 May 2015
Australia launched an online register of clinical trials so that patients can search for potential treatment opportunities as recruitment falls short for many Phase III efforts in the country, the Australian newspaper reported.
NIH announces winning teams of Neuro Startup Challenge to commercialize its inventions
22 May 2015
The National Institutes of Health announced the 16 winning teams of the Neuro Startup Challenge. They were chosen to commercialize its unlicensed technologies to improve brain health
Japan eyes higher target for generics despite missing earlier aims
22 May 2015
Although it has not even reached its goal of generics comprising 60% of drugs prescribed in Japan, the government is about to raise it to 80% or 90%, according to reports.
Moral imperatives and slippery slopes: Seeking bioethical consensus
22 May 2015
Just because we can, should we? One of humanity's age-old questions took center stage at the two-day BEINGS 2015 meeting, during which delegates began laying the groundwork for what is hoped to become a consensus document setting ethical principles, policies and guidelines in the area of cellular biotechnology, which includes stem cell science and the rapidly advancing gene-editing technologies.
China plans for the long march in biomedical, device reforms
21 May 2015
China, the country of 5-year plans, has inaugurated a longer one: 10 years for increased manufacturing, including biomedicine and high-end medical devices. The State Council calls it "Made in China 2025."
Awareness isn't enough: Pharma needs to focus on action campaigns
21 May 2015
May is the most crowded disease awareness month of the year, but a recent paper published in the American Journal of Public Health suggests it's mostly for naught. While "awareness days" do spread the word about a particular condition, the events seem to have little effect on public health.
China scraps 15% drug markup at 100 hospitals, to move nationwide by 2017
20 May 2015
China's State Council plans to scrap a 15% markup on drug sales in major hospital nationwide, kicking into gear a pilot that aims to transform pharmaceutical cost and quality problems over a two-year horizon as part of a major health system overhaul.
FierceDrugDelivery's 10 biggest partnerships in drug delivery
20 May 2015
"Cover all the bases" is the theme of FierceDrugDelivery's annual list of the top drug delivery partnerships. Finding 10 significant alliances that represent the full range of drug delivery advances was a challenge, and there are certainly other deals out there that are both novel and of high importance.
Study Looks at Diagnostic Utility of Clinical Whole-Genome Sequencing
20 May 2015
Whole-genome sequencing continues to show promise for diagnosing genetic disorders in the clinic, according to a new analysis in Nature Genetics, which sifted through factors involved in reliably narrowing in on authentic disease-causing variants from genome sequences for individuals with Mendelian or immunological conditions.
ICYMI: New Oncology Trend Report Highlights the Future Promise of Innovation
20 May 2015
As part of our Healthy Outlook: Conquering Cancer in the 21st Century blog series, we wanted to highlight a new report from IMS Institute for Healthcare Informatics that examines the global market for oncology treatment. According to the report, cancer care is evolving and improving as new therapies emerge and innovation continues, underscoring the importantance of a competitive biopharmaceutical marketplace to control costs and push biopharmaceutical manufacturers to innovate.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Four cancer centers opened in Russia in 2023
26 April 2024
Russia and the UAE can simplify the drug registration process
26 April 2024
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024